Matt Spraker

A blog post on CHALLENGE and why you should be prescribing exercise today #ASCO25 A 🧵 with some resources for you:

One of our stellar @ASCO LDP mentees this year, @NiuSanford @utswcancer, has put together a phenomenal series of online lectures on @YouTube (totally free!) detailing different aspects of #radonc. There is certainly some focus on GI onc, her specialty, but I think every #hemeonc…

Very nice open access guideline! Pelvic floor PT made the text but not the table. I love it for men and women with lower GI cancers. @NiuSanford @KrishanJethwa @nbn426

We’re live! Check out our new website: ✅ See the latest news ✅ Sign up for email updates ✅ Learn about our objectives ✅ Help spread awareness Start exploring today → worldradiotherapy.org #WorldRTDay #WRAD #OneVoiceForRadiotherapy

This is cool. Click your state for a really fact sheet.

"...our #healthcare system as a whole is riddled by parasites such as #insurancecompanies and #admin." "public sees #doctors making six or seven figures and assumes they are to blame, even though #HealthInsurance #CEOs routinely earn $20 million or more."…

Absolutely. I’m not surprised this post was so popular. Over the past year, I’ve also had an increasing # of patients interested in ivermectin. Agree we need to do much better at communicating evidence & setting expectations. But what about going a step further? Since one person…

Pssst… it’s not just the insurance companies. Look at hospital revenues. They’re the ones driving this. Every federal policy promotes consolidation. More consolidation, higher prices. Higher prices, higher insurance premiums.

The Force was with us today @UTSW_RadOnc! We treated our first HANSOLO patient using Ethos: Head And Neck radiotherapy with Simulation Omitted and setup and pLanning Online. Patient needed emergent radiotherapy to control bleeding but may receive definitive treatment later,…

The core problem with present day academia is that there are great incentives for dishonesty, and great disincentives for policing dishonesty. Peer review itself is a thankless task that doesn’t advance one’s career and is not always done to the most rigorous standards. Data…

We have hand outs we use in clinic with trusted manufacturers that we have seen good outcomes, we share these with whoever wants them. I have emailed members MSK, Anderson, NW, Mayo and many others. I think it’s important to know this is a good option

But agree it isn’t good for all situations, but once you start getting your patients off chronic steroids and I’ve had peds rad oncs all over the world call me saying it’s been amazing having their patients finally off steroids. So my wish is that we get the word out!!

Physician 😘 (And on my way to board certification in integrative medicine, by the way)

Sometimes yes, but often no. Boswellia is a lot of pills, variable quality and people getting it from unclear sources, and we have decades of data for steroids. If the stakes are high, it’s a bad choice for first line. Don’t get carried away with the shiny new thing.